These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3055180)

  • 1. Interactions of new plasmid-mediated beta-lactamases with third-generation cephalosporins.
    Labia R; Morand A; Tiwari K; Sirot J; Sirot D; Petit A
    Rev Infect Dis; 1988; 10(4):885-91. PubMed ID: 3055180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic properties of two plasmid-mediated beta-lactamases from Klebsiella pneumoniae with strong activity against third-generation cephalosporins.
    Labia R; Morand A; Tiwari K; Pitton JS; Sirot D; Sirot J
    J Antimicrob Chemother; 1988 Mar; 21(3):301-7. PubMed ID: 3283096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kinetics of CAZ-5, a novel SHV-related plasmid-mediated beta-lactamase with enhanced hydrolytic activity against ceftazidime.
    Labia R; Thabaut A; Morand A; Tiwari K; Sirot D; Sirot J
    Drugs Exp Clin Res; 1989; 15(11-12):535-40. PubMed ID: 2700319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kinetics of SHV-2 plasmid-mediated beta-lactamase compared to those of the parent enzyme from which it is derived.
    Labia R; Morand A; Tiwari K; Pitton JS; Sirot D; Sirot J; Ben Yaghlane H; Boujenah A
    Drugs Exp Clin Res; 1988; 14(5):335-9. PubMed ID: 3065020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasmid resistance to 3d generation cephalosporins].
    Philippon A; Paul G; Vedel G; Nevot P
    Presse Med; 1988 Oct; 17(37):1883-9. PubMed ID: 2973578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.
    Payne DJ; Marriott MS; Amyes SG
    J Med Microbiol; 1990 Jun; 32(2):131-4. PubMed ID: 2192063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Behavior of ceftazidime in regard to different classes of beta-lactamases. The situation in 1988].
    Labia R; Barthélémy M; Peduzzi J; Morand A; Tiwari K
    Presse Med; 1988 Oct; 17(37):1890-4. PubMed ID: 2973579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel plasmid-mediated extended-spectrum beta-lactamase not derived from TEM- or SHV-type enzymes.
    Bernard H; Tancrede C; Livrelli V; Morand A; Barthelemy M; Labia R
    J Antimicrob Chemother; 1992 May; 29(5):590-2. PubMed ID: 1624397
    [No Abstract]   [Full Text] [Related]  

  • 9. TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli.
    Paul GC; Gerbaud G; Bure A; Philippon AM; Pangon B; Courvalin P
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1958-63. PubMed ID: 2692515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Close amino acid sequence relationship between the new plasmid-mediated extended-spectrum beta-lactamase MEN-1 and chromosomally encoded enzymes of Klebsiella oxytoca.
    Barthélémy M; Péduzzi J; Bernard H; Tancrède C; Labia R
    Biochim Biophys Acta; 1992 Jul; 1122(1):15-22. PubMed ID: 1633193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-spectrum plasmid-mediated beta-lactamases.
    Sirot D
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():19-34. PubMed ID: 8543494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated beta-lactamases markedly active against third-generation cephalosporins: epidemiologic studies.
    Sirot J; Chanal C; Petit A; Sirot D; Labia R; Gerbaud G
    Rev Infect Dis; 1988; 10(4):850-9. PubMed ID: 3055177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives of beta-lactamases inhibitors in therapy of infections caused by Escherichia coli or Klebsiella with plasmidic resistance to third generation cephalosporins.
    Bauernfeind A
    Infection; 1990; 18(1):48-52. PubMed ID: 2179138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Klebsiella oxytoca beta-lactamases: study of their action on 3d-generation cephalosporins].
    Labia R; Morand A; Guionie M; Heitz M; Pitton JS
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):611-5. PubMed ID: 3534754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of meropenem, with beta-lactamases, including enzymes with extended-spectrum activity against third-generation cephalosporins.
    Labia R; Morand A; Tiwari K; Sirot D; Chanal C
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():219-23. PubMed ID: 2808209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TEM beta-lactamase mutants hydrolysing third-generation cephalosporins. A kinetic and molecular modelling analysis.
    Raquet X; Lamotte-Brasseur J; Fonzé E; Goussard S; Courvalin P; Frère JM
    J Mol Biol; 1994 Dec; 244(5):625-39. PubMed ID: 7990143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-lactamases involved in resistance to broad-spectrum cephalosporins in Escherichia coli and Klebsiella spp. clinical isolates collected between 1994 and 1996, in Barcelona (Spain).
    Sabaté M; Miró E; Navarro F; Vergés C; Aliaga R; Mirelis B; Prats G
    J Antimicrob Chemother; 2002 Jun; 49(6):989-97. PubMed ID: 12039891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of five plasmid-mediated ceftazidimases isolated in Klebsiella pneumoniae.
    Sirot D; Chanal C; Labia R; Meyran M; Sirot J; Cluzel R
    J Antimicrob Chemother; 1989 Oct; 24(4):509-21. PubMed ID: 2693430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams.
    Gutmann L; Ferré B; Goldstein FW; Rizk N; Pinto-Schuster E; Acar JF; Collatz E
    Antimicrob Agents Chemother; 1989 Jun; 33(6):951-6. PubMed ID: 2669628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins.
    Kliebe C; Nies BA; Meyer JF; Tolxdorff-Neutzling RM; Wiedemann B
    Antimicrob Agents Chemother; 1985 Aug; 28(2):302-7. PubMed ID: 3879659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.